medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2009, Número 07

<< Anterior

Ginecol Obstet Mex 2009; 77 (07)


Guías de práctica clínica 2008. Colegio Mexicano de Especialistas en Ginecología y Obstetricia

Idioma: Español
Referencias bibliográficas: 83
Paginas: 177-209
Archivo PDF: 670.05 Kb.


RESUMEN

Introducción: a pesar de la gran cantidad de información en la literatura médica existe una gran controversia y divergencia de opiniones en el manejo de estas pacientes, por lo que esta revisión pretende ser una guía y contestar las preguntas más importantes concernientes al manejo de la ruptura prematura de membranas pretérmino, de acuerdo con la evidencia científica actual en la literatura.
Objetivo: revisar la literatura médica relacionada con la ruptura prematura de membranas y recomendar el manejo basado en evidencia científica.
Material y métodos: se efectuó una revisión de la literatura en The Cochrane Library y PubMed para la búsqueda de guías de práctica clínica, estudios controlados con asignación al azar, revisiones sistemáticas y meta-análisis, del periodo de 1983 a 2007.
Resultados: las pacientes con ruptura prematura de membranas (RPM), entre la viabilidad fetal y antes de las 32 semanas, deben manejarse de forma expectante si no existen contraindicaciones maternas o fetales. Se deben manejar con un curso único de esteroides y antibióticos por 7 días.
Conclusiones: esta Guía de Práctica Clínica permite plasmar consenso en el manejo de la ruptura prematura de membranas y efectuar recomendaciones para disminuir la variabilidad de la atención y mejorar la calidad de la práctica clínica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Scott TC, Kimberly G, Calvin H. Premature rupture of the membranes: an evidence-based approach to clinical care. Am J Perinatol 2001;18:397-413.

  2. Mercer B. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178- 93.

  3. ACOG Practice Bulletin Number 80. Clinical management guidelines for obstetrician-gynecologists. Premature rupture of membranes. April, 2007.

  4. Mercer B, Preterm premature rupture of the membranes: current approaches to evaluation and management. Obstet Gynecol Clin N Am 2005;32:411-28.

  5. Royal College of Obstetricians and Gynecologist. Preterm prelabour rupture of membranes. Green-Top Guideline No, 44. London: RCOG;2006.

  6. Bottoms SF, Paul RH, Mercer BM, MacPherson CA, Caritis SN, et al. Obstetric determinants of neonatal survival: antenatal predictors of neonatal survival and morbidity in extremely low birth weight infants. Am J Obstet Gynecol 1999;180:665-9.

  7. Seo K, Mc Gregor JA, French JI. Preterm birth is associated with increased risk of maternal and neonatal infection. Obstet Gynecol 1992;180:665-9.

  8. Lamont RF. Recent evidence associated with the condition of preterm prelabour rupture of the membranes. Curr Opin Obstet Gynecol 2003;15:91-99.

  9. Romero R. Premature rupture of the membranes. In: Reece A, Hobbins J. Medicine of the fetus and mother. 2nd ed. Philadelphia: Lippincott-Raven, 1998;pp:1581-625.

  10. Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome (FIRS). Am J Obstet Gynecol 1998;179:194.

  11. Allahyar J, Galan H. Premature rupture of membranes, emedicine, August, 2006.

  12. Galask RP, Varner MW, Petzold CR, Wilbur SL. Bacterial attachment to the chorioamniotic membranes. Am J Obstet Gynecol 1984;915-28.

  13. Gyr TN, Malek A, Mathez-L, Altermatt HJ, Bodmer R, et al. Permeation of human chorioamniotic membranes by Escheriquia coli in vitro. Am J Obstet Gynecol 1994;170:223-7.

  14. Murtha AP, Sinclair I, Hauser ER, Swamy GK, et al. Maternal serum cytokines in preterm premature rupture of membranes. Am J Obstet Gynecol 2007;109:121-7.

  15. Schutte MF, TreffersPE, Lkoosterman GJ, et al. Management of premature rupture of membranes: the risk of vaginal examination to the infant. Am J Obstet Gynecol 1983;146:395.

  16. Lewis OF, Major CA, Towers CV, Asrat I, et al. Efects of digital vaginal examinations on latency period in preterm premature rupture of membranes. Obstet Gynecol 1992;80:630-4.

  17. Gaucherand P, Guibaud S, Awada A, Rudigoz RC. Comparative study of three amniotic fluid markers in premature of membranes: fetal fibronectin, alpha-fetoprotein, diamino-oxydase. Acta Obstet Gynecol Scand 1995;74:1058-61.

  18. Lewis OF, Robichaux AG, Jaekle RK, Salas A, et al. Expectant management of preterm preS207 Manejo de ruptura prematura de membranas pretérmino Volumen 77, Suplemento 7, 2009 mature rupture of membranes and non vertex presentation: what are the risk? Am J Obstet Gynecol 2007;196:566.

  19. National Guideline Cleringhouse. Premature rupture of membranes 1998-2007.

  20. Carroll SG, Papaioannou S, Ntumazah IL, Philpott-Howard J, Nikolaides KH. Lower genital tract swabs in the prediction of intrauterine infection in preterm prelabour rupture of membranes. BJOG 1996;103:54-59.

  21. Mercer B, Moretti M, Shaver O, et al. Intensive antenatal testing for women with preterm premature rupture of membranes, Am J Obstet Gynecol 1991;164:362,

  22. Vintzileos AM, Campbell WA, Nochimsom OJ, et al. The use of nonstress test in patients with premature rupture of the membranes. Am J Obstet Gynecol 1986;155:149-53.

  23. Hanley ML, Vintzileos AM. Boiphysical testing in premature rupture of the membranes. Semin Perinatol 1996;20:418-25.

  24. Romero-Arauz JF, Martinez-Chequer JC, Garcia-Alonso, Lopez A, et al. Utilidad del perfil biofísico fetal en la rotura prematura de membranas pretérmino con tratamiento. Ginecol Obstet Mex 2005;73:415-23.

  25. Vintzileos MA, Campbell WA, Nochimsom JO. The fetal biophysical profile in patients with premature rupture of the membranes. An early predictor of fetal infection. Am J Obstet Gynecol 1985;152:510-6.

  26. Mercer BM, Rabello YA, Thurnau GR, Miodovnik M, et al. The NICHO-MFMU antibiotic treatment of preterm PROM study: impact of initial amniotic fluid volume on pregnancy outcome, NICHO-MFMU Network. Am J Obstet Gynecol 2006;194:438-45.

  27. Yucel N, Yucel O, Yekeler H. The relationship between umbilical artery Doppler findings, fetal biophysical score and placental inflammation in cases of premature rupture of the membranes. Acta Obstet Gynecol Scand 1997;76:532-5.

  28. Blackwell SC, Berry SM. Role of amniocentesis for the diagnosis of subclinical intra-amniotic infection in preterm premature rupture of the membranes. Curr Opin Obstet Gynecol 1999;11:541-47.

  29. Romero R, Yoon B, Mazor M, Gómez R, et al. A comparative study of the diagnostic performances of amniotic fluid glucose, white blood cell count, interleukin-6, and Gram stain in the detection of microbial invasion in patients with premature rupture of the membranes. Am J Obstet Gynecol 1993;169:839.

  30. Naef RW, Albert JR, Ross EI, et al. Premature rupture of the membranes at 34 to 37 weeks of gestation: aggressive versus conservative management. Am J Obstet Gynecol 1998;178:126-30.

  31. Jazayeri A. Jazayeri MK, Sutkin G. Tocolysis does not improve neonatal outcome in patients with preterm rupture of the membranes. Am J Perinatol 2003;20:189-93.

  32. Garite TJ, Keegan KA, Freeman RK, Negeotte MP. A randomized trial of ritodrine tocolysis versus expectant management in patients with premature rupture of the membranes at 25 to 30 weeks of gestation, Am J Obstet Gynecol 1987;157:388-93.

  33. Combs CA, McCune M, Clark R, Fishman A. Aggressive tocolysis does not prolong pregnancy or reduce neonatal morbidity after preterm rupture of the membranes. Am J Obstet Gynecol 2004;190:1728-31.

  34. Mercer B. Is there a role for tocolytic therapy during conservative management of preterm premature rupture of the membranes? Clin Obstet Gynecol 2007;50:487-96.

  35. Vergani P, Ghidini A, Locatelli A, Cavallone M, et al. Risk factors for pulmonary hypoplasia in second trimester premature rupture of membranes. Am J Obstet Gynecol 1994;170:1359-6.

  36. Harding JE, Pang J, Knigth DB, Liggins GC. Do antenatal corticosteroids help in the setting of preterm rupture of the membranes. Am J Obstet Gynecol 2001;184:139-9.

  37. Lewis OF, Brody K, Edwards MS, et al. Preterm premature rupture of the membranes: a randomized trial of steroids after treatment with antibiotics, Obstet Gynecol 1996;88:801-5.

  38. Pattinson RC, Makin JD, Funk M et al. The use of dexamethasone in women with preterm premature rupture of the membranes: a multicentre double blind, placebo controlled, randomized trial. Dexiprom Study Group. S Afr Med J 1999;89:865-70.

  39. Antenatal corticosteroid therapy for fetal maturation. ACOG Committee Opinion No, 273. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;99:871-3.

  40. Royal College of Obstetricians and Gynaecologists. Antenatal corticosteroids to prevent respiratory distress syndrome, Green-top Guideline No. 7. London: RCOG; 2004.

  41. Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes. [Systematic Review] Cochrane Pregnancy and Childbirth Group Cochrane Database of Systematic Reviews; 2008.

  42. Neilson MJ. Antibiotics for preterm rupture of membranes. Cochrane Database of Systematic Reviews 2003. Issue 2.

  43. Fuhr, Norbert A. Antibiotic therapy for preterm premature rupture of membranes - results of a multicenter study. J Perin Med 2006;34(3):203-6.

  44. Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Database of Systematic Reviews 2003. Issue 2.

  45. Egarter C, Leitich H, Karas H, Wieser F, et al. Antibiotic treatment in premature rupture of membranes and neonatal morbidity: a meta-analysis. Am J Obstet Gynecol 1996;174:589-97.

  46. Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 1997;278:989-95.

  47. Kenyon SL, Taylor OJ, Tarnow-Mordi W. Broad spectrum antibiotics for preterm, prelabor rupture of fetal membranes: the ORACLE I randomized trial, ORACLE Collaborative Group [published erratum appears in Lancet 2001;358:156]. Lancet 2001;357:979-88.

  48. Lewis OF, Adair CD, Robichaux AG, Jaekle RK, et al. Antibiotic therapy in preterm premature rupture of membranes: are seven days necessary? A preliminary, randomized clinical trial. Am J Obstet Gynecol 2003;188:1413-6.

  49. Segel SY, Miles AM, Clothier B, Parry S, Macones GA. Duration of antibiotic therapy after preterm premature rupture of fetal membranes. Am J Obstet Gynecol 2003;189:799-802.

  50. American College of Obstetricians and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion No. 289. Obstet Gynecol 2002;100:1405-12.

  51. Carlan SJ, O’Brien WF, Parsons MT, Lense JJ. Preterm premature rupture of membranes: a randomized study of home versus hospital management. Obstet Gynecol 1993;81:61-64.

  52. McElrath TF, Norwitz ER, Lieberman ES, Heffner LJ. Management of cervical cerclage and preterm premature rupture of membranes: should the stitch be removed? Am J Obstet Gynecol 2000;183:840-6.

  53. Blickstein I, Katz Z, Lancet M, Molgilner BM. The outcome of pregnancies complicated by preterm rupture of the membranes with and without cerclage. Int J Gynaecol Obstet 1989;28:237-42.

  54. Yeast JD, Garite TR. The role of cervical cerclage in the management of preterm premature rupture of the membranes. Am J Obstet Gynecol 1988;158:106-10.

  55. Ludmir J, Bader T, Chen L, Lindenbaum C, Wong G. Poor perinatal outcome associated with retained cerclage in patients with premature rupture of membranes. Obstet Gynecol 1994;84:823-6.

  56. McElrath TF, Norwitz ER, Lieberman ES, Heffner LJ. Perinatal outcome after preterm premature rupture of membranes with in situ cervical cerclage. Am J Obstet Gynecol 2002;187:1147-52.

  57. Jenkins TM, Berghella V, Shlossman PA, Mcintyre CJ, et al. Timing of cerclage removal after preterm premature rupture of membranes: maternal and neonatal outcomes. Am J Obstet Gynecol 2000;183:847-52.

  58. Berghella V, Seibel-Seamon. Contemporary use of cervical cerclage. Clin Obstet Gynecol. 2007;50(2):468-77.

  59. American College of Obstetricians and Gynecologists. Management of herpes in pregnancy, practice bulletin 8;1999.

  60. Whitely R, Arvin A, Prober C, Corey L, et al. Predictors of morbility and mortality in neonates with herpes simplex infections: the National Institute of Allergy and Infections Diseases Collaborative Antiviral Study Group. N Engl J Med 1991;324:450-4.

  61. Brown ZA, Benedetti J, Ashley R, Burchett S, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324:1247- 52, (Nivel de evidencia II-1).

  62. Gibbs RS, Amstey MS, Lezotte DC. Role of cesarean delivery in preventing neonatal herpes virus infection. JAMA 1993;270:94-95.

  63. Major CA, Towers CV, Lewis OF, Garite TJ. Expectant management of preterm premature rupture of membranes complicated by active recurrent genital herpes. Am J Obstet Gynecol 2003;188:1551-5.

  64. Boucher FD, Yasukawa LL, Bronzari RN, Hensleigh PA, et al. A prospective evaluation of primar genital herpes simplex virus type 2 infections acquired during pregnancy. Pediatr Infect Dis J 1990;9:499-504.

  65. Minkoff H. Human immunodeficiency virus infection in pregnancy. Obstet Gynecol 2003;101(4):797-810.

  66. Landesman S, Kalish L, Burns O, Minkoff H, et al. The relationship of obstetrical factors to the mother-to-child transmission of HIV-1. N Engl J Med 1996;334:1617-23.

  67. Loannidis JPA, Abrams EJ, Ammann A, Bulterys M, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis 2001;183:539-45.

  68. Minkoff H, Burns ON, Landesman S, et al. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 1995;173:585-9.

  69. Read JS, Newell ML. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1, [Systematic Review] Cochrane HIV/AIDS Group Cochrane Database of Systematic Reviews. 1, 2008.

  70. The International Perinatal HIV Group, Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies. AIDS 2001;15(3):357-68.

  71. Watts DH. Drug Therapy: management of human immunodeficiency virus infection in pregnancy. Review article. N Engl J Med 2002;346(24):1879-91.

  72. Culnane M, Fowler M, Lee SS, McSherry G, et al. Lack of long-term effects of in uterus exposure to zidovudine among uninfected children born to HIV-infected women. JAMA 1999;281:151-7 (Nivel de evidencia III).

  73. Verma U, Goharkhay N, Beydoun S. Conservative management of preterm premature rupture of membranes between 18 and 23 weeks of gestation-maternal and neonatal outcome. Eur J Obstet Gynecol Reprod Biol 2006;128:119-24.

  74. Perinatal care at the threshold of viability. ACOG Practice Bulletin No. 38. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;100:617-24.

  75. Yoshimura S, Masuzaki HI, Gotoh H, Fukuda H, Ishimaru T. Ultrasonographic prediction of lethal pulmonary hypoplasia: comparison of eight different ultrasonographic parameters. Am J Obstet Gynecol 1996;175:477-83 (Nivel de evidencia II)

  76. Lauria MR, Gonik B, Romero R. Pulmonary hypoplasia: pathogenesis, diagnosis, and antenatal prediction. Obstet Gynecol 1995;86:466-75.

  77. D’Alton M, Mercer B, Riddick E, Dudley O. Serial thoracic versus abdominal circumference ratios for the prediction of pulmonary hypoplasia in premature rupture of the membranes remote from term. Am J Obstet Gynecol 1992;166:658-63.

  78. Vintzileos AM, Campbell WA, Rodis JF, Nochimson OJ, et al. Comparison of six different ultrasonographic methods for predicting lethal fetal pulmonary hypoplasia. Am J Obstet Gynecol 1989;161:606-12.

  79. De Santis M, Scavvo M, Noia G, Masini I, et al. Transabdominal amnioinfusion treatment of severe oligohydramnios in preterm premature rupture of membranes at less than 2ó gestational weeks. Fetal Diagn Ther 2003;18:412-17.

  80. Ogunyemi O, Thompson W. A case controlled study of serial transabdominal amnioinfusion in the management of second trimester oligohydramnios due to preterm premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol 2002;102:81.

  81. Nageotte MP, Freeman RK, Garite TJ, Dorchester W. Prophylactic intrapartum amnioinfusion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1985;153:557- 62.

  82. Cousins LM, Smok DP, Lovett SM, Poeltler OM. Amnisure placental alpha microglubin-1 rapid immnunossay versus standard diagnostic methods for detection of rupture of membranes. Am J Perinatal 2005;22:317-20.

  83. Caughey AB, Parer JT. Recommendations for repeat courses of antenatal corticosteroids: a decision analysis. Am J Obstet Gynecol 2002;186:1221-9.




2020     |     www.medigraphic.com